Cost-effectiveness of cataract surgery

Current Opinion in Ophthalmology

Volumn 22, Issue 1, 2011, Pages 15-18

  Agarwal, Amar ^a   Kumar, Dhivya Ashok ^a  

^a Dr Agarwal's Eye Hospital   (India)

Author keywords

Cataract surgery cost; Cost utility; Cost benefit analysis; Cost effectiveness

Indexed keywords

ARTICLE; CATARACT EXTRACTION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; DAY CARE; DEVELOPED COUNTRY; HOSPITAL PATIENT; HUMAN; INDIA; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; TREATMENT OUTCOME;

CATARACT EXTRACTION; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; HEALTH CARE COSTS; HUMANS; INDIA; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES;

EID: 79955026586     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e3283414f64     Document Type: Article

References (35)

1. Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ 1995;73:115-121.
2. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82:844-851. (Pubitemid 39573742)
3. Roodhooft JM. Leading causes of blindness worldwide. Bull Soc Belge Ophtalmol 2002;283:19-25.
4. Foster A. Cataract and 'VISION 2020: the right to sight' initiative. Br J Ophthalmol 2001;85:635-637. (Pubitemid 32554233)
5. World Health Organization. Global initiative for the elimination of avoidable blindness: vision 2020 launched in English speaking Africa, South Africa set to eliminate cataract blindness within the next five years. Press Release WHO/27, Johannesburg, South Africa: 19 April 2000, WHO, document PR-2000-27. Available at http:www.who.int/inf-pr-2000/en/pr2000-27.html
6. World Health Organization programme for the prevention of blindness and deafness. Global initiative for the elimination of avoidable blindness. World Health Organization Programme for the Prevention of Blindness and Deafness. Document no.: WHO/PBL/97.61 Rev. 1; Geneva: 1997, WHO, unpublished document available at http://whqlibdoc.who.int/hq/1997WHO-PBL-97.61-Rev. 1.pdf.
7. Murray CJL, Lopez AD. A Comprehensive assessment of mortality and disability from disease, injuries, and risk factors in 1990 and projected to 2020. In Murray CJL, Lopez AD, editors. The global burden of disease. Cambridge (MA): Harvard School of Public Health; 1996.
8. Brown MM, Brown GC. Howto interpret a healthcare economicanalysis. Curr Opin Ophthalmol 2005;16:191-194.
9. Lansingh VC, Carter MJ, Martens M. Global cost-effectiveness of cataract surgery. Ophthalmology 2007;114:1670-1678. (Pubitemid 47332658)
10. Busbee BG, Brown MM, Brown GC, Sharma S. Incremental cost-effectiveness of initial cataract surgery. Ophthalmology 2002;109:606-612. (Pubitemid 34184933)
11. Brown MM, Brown GC. Cost-effective analysis. The value component of evidence-based medicine. Evidence-Based Eye Care 2000;1:243-247.
12. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977;296:716-721. (Pubitemid 8066534)
13. Torrance GW. Utility approach to measuring health-related quality of life [review]. J Chronic Dis 1987;40:593-603.
14. Torrance GW, Feeny D. Utilities and quality-adjusted life years. Int J Technol Assess Healthcare 1989;5:559-575. (Pubitemid 20153102)
15. Lansingh VC, Carter MJ. Use of Global Visual Acuity Data in a time trade-off approach to calculate the cost utility of cataract surgery. Arch Ophthalmol 2009;127:1183-1193. This reference shows that time trade-off (TTO) analysis can be used to determine the cost utility of cataract surgery.
16. Brown GC, Brown MM, Sharma S, et al. Cost-effectiveness of treatment for threshold retinopathy of prematurity. Pediatrics 1999;104: e47.
17. Brown GC, Brown MM, Sharma S, et al. Incremental cost-effectiveness of laser photocoagulation for subfoveal choroidal neovascularization. Ophthalmology 2000;107:1374-1380.
18. Brown GC, Brown MM, Sharma S, et al. Incremental cost-effectiveness of laser therapy for choroidal neovascularization associated with histoplasmosis. Retina 2000;20:331-337.
19. Baltussen R, Sylla M, Mariotti SP. Cost-effectiveness analysis of cataract surgery: a global and regional analysis. Bull World Health Organ 2004;82:338-345. This study analyzes the cost-effectiveness of cataract surgery in 14 epidemiological subregions. (Pubitemid 38715070)
20. Sirtoli MG, Santhiago MR, Parede TR, et al. Phacoemulsification versus extra-capsular extraction: governmental costs. Clinics (Sao Paulo) 2010;65:357-361. The study shows that phacoemulsification is an efficient procedure with regard to the impact on public healthcare system.
21. Smith AF, Lafuma A, Berdeaux G, et al. Cost-effectiveness analysis of PMMA, silicone, or acrylic intra-ocular lenses in cataract surgery in four European countries. Ophthalmic Epidemiol 2005;12:343-351. (Pubitemid 41702802)
22. Minasian DC, Mehera V. 3.8 Million blinded by cataract each year: projections of the first epidemiological study of incidence of cataract blindness in India. Br J Ophthalmol 1990;74:341-343.
23. Jose R. National programme for the control of blindness. Ind J Comm Health 1997;3:5-9.
24. Shamanna BR, Dandona L, Rao GN. Economic burden of blindness in India. Ind J Ophthalmol 1998;46:169-172. (Pubitemid 128519395)
25. Muralikrishnan R, Venkatesh R, Prajna NV, Frick KD. Economic cost of cataract surgery procedures in an established eye care centre in Southern India. Ophthalmic Epidemiol 2004;11:369-380. (Pubitemid 40095931)
26. Singh AJ, Garner P, Floyd K. Cost-effectiveness of public-funded options for cataract surgery in Mysore, India. Lancet 2000;355:180-184. (Pubitemid 30068216)
27. Gogate PM, Deshpande M, Wormald RP. Is manual small incision cataract surgery affordable in the developing countries? A cost comparison with extracapsular cataract extraction. Br J Ophthalmol 2003;87:843-846. (Pubitemid 36765245)
28. Gogate P, Deshpande M, Nirmalan PK. Why do phacoemulsification? Manual small-incision cataract surgery is almost as effective, but less expensive. Ophthalmology 2007;114:965-968. (Pubitemid 46635834)
29. Radhakrishnan M, Venkatesh R, Ravindran RD. Cost-effectiveness. Ophthalmology 2008;115:211.
30. Gogate P, Deshpande M. Cost-effectiveness (author reply). Ophthalmology 2008;115:212.
31. Brown MM, Brown GC, Sharma S, et al. Quality of life associated with unilateral and bilateral good vision. Ophthalmology 2001;108:643-647; discussion 647-8. (Pubitemid 32238453)
32. Busbee BG, Brown MM, Brown GC, Sharma S. Cost-utility analysis of cataract surgery in the second eye. Ophthalmology 2003;110:2310-2317. (Pubitemid 37485160)
33. Sach TH, Foss AJ, Gregson RM, et al. Second-eye cataract surgery in elderly women: a cost-utility analysis conducted alongside a randomized controlled trial. Eye (Lond) 2010;24:276-283. In the long term, second-eye cataract surgery appears to be cost-effective unless carer costs are included.
34. Fedorowicz Z, Lawrence D, Gutierrez P. Day care versus in-patient surgery for age-related cataract. Cochrane Database Syst Rev 2005; CD004242.
35. Dave H, Phoenix V, Becker ER, Lambert SR. Simultaneous vs. sequential bilateral cataract surgery for infants with congenital cataracts: visual outcomes, adverse events, and economic costs. Arch Ophthalmol 2010;128:1050-1054. This paper is a retrospective review of simultaneous vs. sequential bilateral cataract surgery for infants with congenital cataracts who underwent cataract surgery when 6 months or younger.